Agilis Robotics Announces $10M Series A Funding for Advancing Flexible Robotic Instruments in Endoscopic Surgery

Agilis Robotics Limited is excited to announce the successful completion of a significant funding round, raising $10 million to further its mission of transforming endoscopic surgery through innovative robotic solutions. A proud spin-off from The University of Hong Kong, Agilis Robotics specializes in the development of flexible robotic instruments that enable enhanced dexterity and precision for clinicians in the operating room. Our technology integrates seamlessly into existing clinical workflows, ensuring that healthcare professionals can deliver the highest standard of care without the steep learning curve often associated with new medical technologies. This new funding will be instrumental in accelerating the development and commercialization of our robotic instruments, allowing us to refine our prototypes and initiate clinical trials. With the healthcare landscape becoming increasingly reliant on minimally invasive procedures, the demand for advanced surgical tools has never been more critical. Our goal is to empower surgeons with tools that not only improve patient outcomes but also streamline their surgical processes. The investment from our latest round will also support strategic partnerships and collaborations, further solidifying our position in the robotics healthcare market. As we look to the future, we remain committed to innovation and excellence, poised to revolutionize the field of endoscopic surgery and enhance the surgical experience for both medical professionals and patients alike. We are grateful for the trust and support of our investors and excited about the journey ahead as we bring our cutting-edge technology to the forefront of medical practice.